These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29766377)

  • 41. [CAPS treatment].
    Jiménez Treviño S; Ramos Polo E
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():29-33. PubMed ID: 21596184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of anakinra on arthropathy in CINCA/NOMID syndrome.
    Miyamae T; Inaba Y; Nishimura G; Kikuchi M; Kishi T; Hara R; Kaneko U; Shinoki T; Imagawa T; Yokokta S
    Pediatr Rheumatol Online J; 2010 Mar; 8():9. PubMed ID: 20230645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery.
    Tanaka T; Takahashi K; Yamane M; Tomida S; Nakamura S; Oshima K; Niwa A; Nishikomori R; Kambe N; Hara H; Mitsuyama M; Morone N; Heuser JE; Yamamoto T; Watanabe A; Sato-Otsubo A; Ogawa S; Asaka I; Heike T; Yamanaka S; Nakahata T; Saito MK
    Blood; 2012 Aug; 120(6):1299-308. PubMed ID: 22723549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes.
    Church LD; McDermott MF
    Expert Rev Clin Immunol; 2010 Nov; 6(6):831-41. PubMed ID: 20979548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade.
    DeSena AD; Do T; Schulert GS
    J Neuroinflammation; 2018 Feb; 15(1):38. PubMed ID: 29426321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.
    Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A
    Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal Fluid Cytokines Correlate With Aseptic Meningitis and Blood-Brain Barrier Function in Neonatal-Onset Multisystem Inflammatory Disease: Central Nervous System Biomarkers in Neonatal-Onset Multisystem Inflammatory Disease Correlate With Central Nervous System Inflammation.
    Rodriguez-Smith J; Lin YC; Tsai WL; Kim H; Montealegre-Sanchez G; Chapelle D; Huang Y; Sibley CH; Gadina M; Wesley R; Bielekova B; Goldbach-Mansky R
    Arthritis Rheumatol; 2017 Jun; 69(6):1325-1336. PubMed ID: 28118536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resolution of unilateral sensorineural hearing loss in a pediatric patient with a severe phenotype of Muckle-Wells syndrome treated with Anakinra: a case report and review of the literature.
    Marchica C; Zawawi F; Basodan D; Scuccimarri R; Daniel SJ
    J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):9. PubMed ID: 29382382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
    Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
    Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [An approach to the patients with cryopyrin-associated periodic syndrome (CAPS) : a new biologic response modifier, canakinumab].
    Yokota S; Kikuchi M; Nozawa T; Kizawa T; Kanetaka T; Miyamae T; Mori MA; Nishikomori R; Takata H; Heike T; Hara T; Imagawa T
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):23-9. PubMed ID: 22374439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
    Topaloglu R; Batu ED; Orhan D; Ozen S; Besbas N
    Pediatr Nephrol; 2016 Apr; 31(4):633-40. PubMed ID: 26563115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early detection of sensorineural hearing loss in Muckle-Wells-syndrome.
    Kuemmerle-Deschner JB; Koitschev A; Tyrrell PN; Plontke SK; Deschner N; Hansmann S; Ummenhofer K; Lohse P; Koitschev C; Benseler SM
    Pediatr Rheumatol Online J; 2015 Nov; 13(1):43. PubMed ID: 26531310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey.
    Rossi-Semerano L; Fautrel B; Wendling D; Hachulla E; Galeotti C; Semerano L; Touitou I; Koné-Paut I;
    Orphanet J Rare Dis; 2015 Feb; 10():19. PubMed ID: 25758134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort.
    Anton J; Calvo I; Fernández-Martin J; Gamir ML; Merino R; Jimenez-Treviño S; Sevilla B; Cabades F; Bou R; Arostegui JI
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S67-71. PubMed ID: 26243511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Muckle-Wells syndrome caused by a new cryopyrin mutation: effective treatment with interleukin-1 antagonist].
    Rameev VV; Kozlovskaia LV; Bogdanova MV
    Ter Arkh; 2012; 84(6):53-9. PubMed ID: 22997920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome.
    Aït-Abdesselam T; Lequerré T; Legallicier B; François A; Le Loët X; Vittecoq O
    Joint Bone Spine; 2010 Dec; 77(6):616-7. PubMed ID: 20609610
    [No Abstract]   [Full Text] [Related]  

  • 57. Successful resolution of stromal keratitis and uveitis using canakinumab in a patient with chronic infantile neurologic, cutaneous, and articular syndrome: a case study.
    Hirano M; Seguchi J; Yamamura M; Narita A; Okanobu H; Nishikomori R; Heike T; Hosokawa M; Morizane Y; Shiraga F
    J Ophthalmic Inflamm Infect; 2015 Dec; 5(1):34. PubMed ID: 26590045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cutaneous neutrophils infiltrates. Case 8. CINCA/NOMID syndrome].
    Fraitag S
    Ann Pathol; 2011 Jun; 31(3):203-7. PubMed ID: 21737003
    [No Abstract]   [Full Text] [Related]  

  • 59. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra.
    Lepore L; Paloni G; Caorsi R; Alessio M; Rigante D; Ruperto N; Cattalini M; Tommasini A; Zulian F; Ventura A; Martini A; Gattorno M
    J Pediatr; 2010 Aug; 157(2):310-315.e1. PubMed ID: 20472245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.